Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Total Non-Current Liabilities readings, the most recent being $676.2 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 0.6% to $676.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $676.2 million, a 0.6% increase, with the full-year FY2025 number at $676.2 million, up 0.6% from a year prior.
  • Total Non-Current Liabilities hit $676.2 million in Q4 2025 for Tandem Diabetes Care, down from $689.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $729.8 million in Q1 2025 to a low of $412.6 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $602.2 million (2022), compared with a mean of $598.5 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 272.17% in 2021 and later fell 0.15% in 2023.
  • Tandem Diabetes Care's Total Non-Current Liabilities stood at $454.2 million in 2021, then rose by 29.67% to $588.9 million in 2022, then grew by 3.1% to $607.2 million in 2023, then rose by 10.7% to $672.2 million in 2024, then grew by 0.6% to $676.2 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $676.2 million (Q4 2025), $689.3 million (Q3 2025), and $690.4 million (Q2 2025) per Business Quant data.